ProteoGenix is a France and USA-based life sciences contract research organization (CRO) specializing in molecular biology and immunology. As a global leader in antibody, protein, peptide, and gene production, ProteoGenix offers flexible and comprehensive end-to-end solutions spanning the full spectrum of biologics development, including polyclonal and monoclonal antibody development, recombinant protein expression and purification, peptide and gene synthesis.

Our commitment to our clients ensures access to integrated and tailored solutions, empowering researchers to efficiently develop the tools they need to conduct their biology and research projects in a time-effective manner. By combining scientific excellence with a client-focused approach, ProteoGenix stands as a trusted partner in fostering the development of next-generation immunotherapies, precision diagnostic tools, and high-quality reagents — contributing to the advancement of life-saving biologics worldwide.